Published date: 29 August 2025

Awarded contract - This means that the contract has been awarded to a supplier.


Closing: 10 March 2025, 1pm

Contract summary

Industry

  • Vaccines - 33651600

Location of contract

E14 4PU

Value of contract

£1

Procurement reference

CF-3099100D0O000000rwimUAA

Published date

29 August 2025

Closing date

10 March 2025

Closing time

1pm

Contract start date

1 October 2025

Contract end date

30 September 2029

Contract type

Supply contract

Procedure type

Open procedure (above threshold)

Any interested supplier may submit a tender in response to an opportunity notice.

This procedure can be used for procurements above the relevant contract value threshold.

Contract is suitable for SMEs?

No

Contract is suitable for VCSEs?

No

Description

Contracts for the supply of vaccine to protect against measles, mumps, rubella and varicella, to be used as part of the national immunisation programme.

Deliveries will be required over a period of 2 years, with an option to extend for up to an additional 24 months.

The awarding of lots is not appropriate for this procurement.

Value - The contract value is withheld from publication pursuant to regulation 50(6)(b) of the Public Contracts Regulations 2015 (as amended) so as not to prejudice the legitimate commercial interest of the supplier.

More information

Attachments

Award information

Awarded date

7 August 2025

Contract start date

1 October 2025

Contract end date

30 September 2029

Total value of contract

£1

This contract was awarded to 2 suppliers.

Merck Sharpe & Dohme (UK) Limited

Address

120 Moorgate, London, EC2M 6UR

Reference

None

Supplier is SME?

No

GlaxoSmithKline UK Ltd - Vaccines

Address

79 New Oxford Street, London, WC1A 1DG

Reference

None

Supplier is SME?

No

About the buyer

Contact name

Lynne Nichols

Address

10 South Colonnade
London
E14 4PU
United Kingdom

Email

vmc.vaccines@ukhsa.gov.uk